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ABSTRACT: Knowledge of proton T2 relaxation time of metabolites is essential for proper quantitation of metabolite
concentrations in localized proton spectroscopy, especially at moderate to long TEs. Although the T2 relaxation time of
singlets, such as that of creatine and N-acetylaspartate, has been characterized in several studies, similar information is
lacking from coupled spin resonances of cerebral metabolites. In this study, the T2 relaxation time of coupled spin resonances
and singlet resonances of cerebral metabolites was measured in rat brain in vivo at 9.4 T. Spectra were acquired at 11
TEs using the SPin ECho, full Intensity Acquired Localized (SPECIAL) spectroscopy method. Data analysis was performed
in the frequency domain with the LCModel software using simulated TE-speciﬁc basis sets. The T2 relaxation times in
compounds showing singlet resonances were 113 3ms (total creatine), 178 29ms (total choline) and 202 12ms
(N-acetylaspartate). The T2 values of J-coupled metabolites ranged from 89 8ms (glutamate) to 148 14ms
(myo-inositol). Copyright # 2007 John Wiley & Sons, Ltd.
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INTRODUCTION
1H MRS is an important tool for investigating brain
metabolism non-invasively. In animal models, the high
spectral resolution and signal-to-noise ratio afforded at
high ﬁelds allow the detection of a neurochemical proﬁle
that includes20metabolites, with 1HMRS performed at
very short TE (1–2ms) (1). At short TE, no losses due to
transverse relaxation occur, and the multiplet resonances
from coupled spin systems display virtually no signal
modulation induced by the J-coupling. As the TE increa-
ses, a loss of signal intensity occurs in singlets because of
transverse relaxation, and in coupled resonances because
of transverse relaxation and J-coupling effects. As the T2
of macromolecule resonances is shorter than that of
cerebral metabolites, a number of 1H MRS studies are
performed at long TE, to avoid the confounding effect of
macromolecular signals on metabolite quantitation. In
addition, 1H MRS editing techniques are typically
performed at moderate to long TE (2,3) dictated by
J-evolution, and therefore, for metabolite quantitation,
the transverse relaxation effect should be taken into
account. This is done by introducing a correction factor
which, however, requires knowledge of the T2 of the
metabolites. A working assumption used in previous
studies was that T2 of coupled resonances is similar to that
of, e.g., creatine (2,3).
Knowledge of T2 relaxation time of metabolites is
essential not only for absolute quantitation of metabolite
concentrations, but also for investigating physiological
and pathological processes. Previous MRS studies of T2
of cerebral metabolites have shown that changes in the
cell microenvironment, induced by pathology or naturally
occurring during development, result in measurable
changes in water and cerebral metabolite T2 relaxation
time (4,5). For example, the increase in T2 of total
choline (tCho) and N-acetylaspartate (NAA) observed
with growth may reﬂect the active myelinogenesis
processes occurring during brain development (4). Thus
T2 of metabolites could also be used to probe the cell
microenvironment so as to provide information on
physiological and pathological processes.
Owing to the relative experimental simplicity, most
studies to date have focused on measurement of the T2 of
singlets (4–6), with the notable exception of citrate in the
prostate (7). To improve metabolite quantitation at
moderate to long TE and to validate previous approaches
based on quantitation by spectral editing, we sought to
determine the T2 for coupled spin resonances. Thus, the
aim of this study was to measure the T2 of coupled spin
resonances of cerebral metabolites in rat brain at 9.4 T
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using a localization sequence based on spin echo [SPin
ECho, full Intensity Acquired Localized (SPECIAL)
spectroscopy] (8) in combination with frequency domain




All animal preparation procedures were in accordance
with local and federal guidelines and were approved by
the local ethics committee. Experiments were performed
on ﬁve healthy Sprague–Dawley rats (318 64 g,
mean SD). During the experiment, the animals were
anesthetized with 1.5% isoﬂurane, and the body
temperature was maintained at 37.58C with circulating
heated water.
MRS
1H MR experiments were performed on a Varian INOVA
console (Varian, Palo Alto, CA, USA) connected to an
actively shielded 9.4 T/31 cm magnet (Magnex Scientiﬁc,
Abingdon, Oxon, UK) with actively shielded gradients
(400mT/m in 120ms, 12 cm inner diameter). A home-
built 14mm diameter 1H quadrature surface coil was used
for radio frequency transmission and signal reception.
In vivo spectra were acquired at 11 echo times (TE¼ 2.8,
20, 40, 60, 80, 110, 130, 150, 170, 200, and 300ms) using
a localization sequence (SPECIAL) that retains full signal
sensitivity by combining a one-dimensional ISIS tech-
nique with a slice-selective spin echo sequence (8).
Brieﬂy, voxel selection is based on a 2ms slice-selective
full-passage adiabatic pulse applied on alternate scans
(resulting in an add–subtract scheme), followed by a spin
echo sequence consisting of 0.5ms 908 and 1808
asymmetric slice-selective pulses with a CYCLOPS
phase cycling scheme (9). A 2.5 5 5mm3 voxel was
centered in the hippocampus of the rat brain. Echo-planar
imaging-based FASTMAP (10) was used to shim a
volume of 3.5 6 6mm3 centered on the measured
volume of interest. After ﬁrst and second order shimming,
the typical linewidth of water resonance at TE¼ 2ms was
12–14Hz. Water suppression was achieved with VAPOR
(11). All spectra were acquired under the following
acquisition parameters: spectral width of 5 kHz, 4096
complex data points, and TR of 4 s. The total scan time per
rat was2 h. Acquisition at each TE (11min) consisted
of 10 free induction decays (16 averages each), which
were saved separately. Fourier transformation and B0 shift
correction were performed before summation of the 10
spectra. A phantom containing 50mM glutamate and
50mM creatine, and pH-balanced (pH¼ 7.0), was
prepared to measure the in vitro T2 of glutamate and
creatine. During themeasurements, the temperature of the
phantom was kept at378C. Spectra were acquired at the
same TEs as in the in vivo measurements. The volume of
interest was 3 5 5mm3, and 64 averages were
accumulated for each spectrum.
Data analysis
Measurements of T2 relaxation time of singlet resonances
are relatively simple because of the absence of
J-modulation effects on the signal intensity. For
resonances of coupled spin systems, the J-modulation
strongly affects both the spectral area (i.e. the signal
intensity) and the spectral lineshape. Thus, to ﬁt the
spectral shape of coupled spin resonances at TE 0, it is
necessary to take into account the effect of J-modulation
on the lineshape (7). A further complication in the
assessment of the T2 relaxation time of coupled spin
resonances arises from the spectral overlap in the
1H spectrum. To overcome these difﬁculties, the
LCModel (12) software was used to analyze spectra at
different echo times. A series of metabolite basis sets of
LCModel for different echo times were created by
quantum mechanics simulations, based on the density-
matrix formalism (13), using published values of
J-coupling constants and chemical shifts (14). In the
basis sets, T2 relaxation was not included; furthermore,
each metabolite was considered as one component, and
thus the T2 reported here is the mean T2 of all proton
groups in the molecule. Additional basis sets with
separate NAA acetyl and aspartate moieties, and the CH3
group and CH2 group of total creatine (tCr), were
prepared to obtain the T2 of different groups in the same
molecule. The ‘apparent’ concentration of each metab-
olite obtained after LCModel analysis decreased with
increasing TE due to T2 relaxation. The Crame´r–Rao
lower bound (CRLB) was provided by LCModel as a
measure of the reliability of the apparent metabolite
concentration quantitation. The mean apparent concen-
trations were obtained from ﬁve rats, and then the T2
relaxation time was calculated by performing a mono-
exponential ﬁt of these apparent concentrations as a
function of TE using the curve-ﬁtting tool of Matlab
(Version 7.1; The MathWorks, Inc., Natick, MA, USA)
combined with the Trust–Region algorithm. For each ﬁt,
the coefﬁcient of determination (R2) was evaluated to
assess the quality of the ﬁt, which was also visually
inspected. T2 values of glutamate and creatine in the
phantom were calculated by the same method.
RESULTS
The J-modulation of the coupled resonance signals was
adequately mimicked by the density-matrix spin simu-
lations, as demonstrated by the good agreement between
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simulated and in vitro spectra of glutamate and creatine
(Fig. 1), and between the ﬁt and in vivo spectra at all echo
times (Fig. 2). At TE¼ 2.8ms, singlets and coupled
resonances were in pure absorption mode. At longer TE,
there was a decrease in the signal intensity, but no change
in the spectral lineshape, of singlets (notably, the
NAA CH3 protons at 2.01 ppm, the tCr CH3 protons at
3.03 ppm, and CH2 protons at 3.92 ppm). On the other
hand, both spectral area (i.e. signal intensity) and spectral
lineshape of coupled spin resonances changed with TE.
With increasing TE, the J-modulation of the signal
intensity was particularly evident for the coupled resonances
of glutamate, myo-inositol, and the aspartate moiety of
NAA. Already at TE of 20ms, a substantial signal modula-
tion was observed in strongly coupled spin systems, such
as the AB spin system of the NAA aspartate moiety at
2.48 and 2.67 ppm. For TE¼ 40–60ms (i.e. TE 1/2J),
the typical antiphase pattern of outer bands was observed
in the triplet of the 4CH and 6CH proton ofmyo-inositol at
3.61 ppm, and in the multiplet of the glutamate CH2
protons at 2.34 ppm (Fig. 2).
When TE approached values of 110–130ms (i.e. TE
1/J), most of the resonances had a positive phase
because of the J-induced rephasing of the signal intensity,
illustrated with, e.g., the glutamate resonances at
2.34 ppm and at 2.03 and 2.12 ppm (Fig. 2). Macromol-
ecular resonance signals decayed within the noise level
after 60–80ms because of their short T2 relaxation time,
and thus the long-TE spectra were characterized by a ﬂat
baseline.
The signal intensity of singlets (data not shown)
decreased monotonically and exponentially with TE. In
contrast with the behavior of singlets, the evolution of the
coupled spin resonances such as glutamate, myo-inositol,
and taurine was more complex (Fig. 3), displaying a steep
and substantial signal loss already at TE of 20ms, mostly
due to J-induced signal dephasing. At longer TE, there
was a ﬁrst signal intensity minimum at TE 60ms and a
relative maximum at 110ms. At even longer TE, the
signal intensity decayed further because of T2 losses and
further J-evolution. The apparent concentrations decrea-
sed with increasing TE because of T2 relaxation in a
nearly mono-exponential fashion (Fig. 3).
To evaluate the accuracy of the metabolite quantitation,
data analysis of the CRLBs, obtained from LCModel
analysis, was performed. Up to TE of 130ms, the CRLBs of
coupled resonances of highly concentrated metabolites such
as glutamate,myo-inositol, and taurinewere below 10%. For
metabolites such as glutamine and g-aminobutyric acid
(GABA), which are present at lower concentration and
also suffer from large overlap with other resonances, the
CRLBs were below 20% at most TEs up to 130ms.
Finally, for TEs up to 200ms, the CRLBs of tCr and
NAAwere below 5%, and the CRLB of tCho was below
10%. Overall, the high spectral resolution and signal-
to-noise ratio afforded at 9.4 T allowed the detection of a
neurochemical proﬁle (13 metabolites) at TE¼ 110ms
with CRLBs < 20%.
In vitro, the T2 values of glutamate, creatine CH3, and
creatine CH2 were 190 20ms (R2¼ 0.9457), 376
19ms (R2¼ 0.9862), and 354 9.5ms (R2¼ 0.9963),
respectively. In rat brain, the T2 relaxation time of the
singlet resonances ranged from 113 3ms (tCr) to
202 12ms (NAA) (Table 1). The T2 of macromolecules
was 19 0.4ms (R2¼ 0.9992). The T2 of coupled
metabolites ranged from 89 8ms (glutamate) to
148 14ms (myo-inositol). The average R2 was above
0.96 for glutamate, myo-inositol, taurine, and phosphor-
ylethanolamine, and in the range 0.78–0.90 for GABA,
glutamine, glucose, and glutathione. With the additional
basis sets, separate T2 values for the NAA methyl
(202 9ms) and aspartyl resonances (131 15ms) and
creatine methyl (115 3ms) and methylene resonances
(101 2ms) were obtained.
Figure 1. (A) In vitro 1H MR spectra of glutamate and
creatine measured using SPECIAL at TE ranging from 2.8
to 110ms (volume of interest¼ 355mm3, TR¼ 4 s, 64
scans, broadened to 12Hz linewidth of the creatine methyl
signal). Because of the longer T1 of the creatine methyl
group, TR¼ 4 s caused greater saturation of the CH3 signal
than of the CH2 signal. (B) Simulated spectra at the same
TEs. Signal intensities are scaled using the in vitro methyl
signal of creatine as a reference. T2 relaxation effect is not
included.
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DISCUSSION
In this study, the T2 relaxation time of coupled spin
resonances of cerebral metabolites was measured in rat
brain in vivo at 9.4 T, beneﬁting from a high spectral
resolution and sensitivity which allowed the measurement
of 13 metabolites even at TE¼ 110ms.
Although the T2 measurement of singlets is compara-
tively straightforward, measurement of T2 of coupled and
especially strongly coupled spin resonances needs to take
into account the complex J-modulation. In this study,
this was accomplished by using the LCModel and
TE-speciﬁc basis sets to ﬁt coupled spin resonances at
different TEs. The LCModel enabled a robust and
rigorous data analysis based on prior knowledge. The
use of simulated spectra as prior knowledge of spectral
evolution at different TE for complex spin systems is
consistent with a previous study, where the T2 relaxation
time of citrate in the prostate was measured (7). Simulated
spectral patterns were validated by comparison with the
in vitromeasurement (Fig. 1), and the spectral appearance
of the ﬁt using the simulated basis set for LCModel
analysis closely matched that observed in vivo at all
TEs (Fig. 2).
The T2 values of the singlets measured in this study
(NAA, tCr, and tCho) were, within experimental error,
comparable to those reported by others in rat (5) and
mouse (4) brain at 9.4 T. Another study reported a longer
T2 for the methyl singlet of, e.g., tCr (171.1 3.9ms) and
NAA (294.3 5.1ms) (6) using the LASER-type
localization method (15). The longer T2 can be explained
by the use of a CPMG-like sequence, which provides a T2
closer to the intrinsic T2 (16).
In vivo, the T2 values of individual groups from creatine
and NAA indicate that the methyl moiety has a longer T2
than CH2 and CH groups, probably because of the faster
rotation of the methyl group. It is of interest to note that
the aspartyl NAAT2 is comparable to that of most coupled
spin resonances measured here, making aspartyl NAA a
suitable internal concentration reference in experiments
where its signal is co-edited, such as in the case of
glutathione detection (2).
Figure 2. (A) In vivowater-suppressed 1HMR spectra of the rat brain measured using SPECIAL at TE ranging from 2.8 to
110ms (volume of interest¼ 2.555mm3, TR¼4 s, 160 scans, Gaussian function weighting: gf¼ 0.12; no baseline
correction, eddy current correction, or post-processing water removal were performed). (B) The LCModel ﬁt of the
corresponding spectrum.
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In virtually all editing techniques, a TE of at least 60ms
(i.e. 1/2J) is used, and therefore the potential effects of
T2 relaxation have to be considered in the quantitation.
Typically, quantitation has been performed by comparing
signal intensity of the edited resonance with that of a
singlet measured at the same TE (2). With the notable
exception of myo-inositol, the T2 relaxation times of
coupled metabolites were within 25% of that of creatine.
Note that, for the frequently edited spin systems such as
GABA and glutathione, T2 was within 10% of that of
creatine, supporting the assumption of similar T2 used in
previous editing studies (2,3,17,18).
As expected, the T2 value of glutamate measured in the
phantom was longer than that measured in vivo in rat
brain. This ﬁnding is consistent with the fact that the T2
relaxation time of metabolites is likely to be sensitive to
the surrounding microenvironment. The method pre-
sented here can be used to investigate T2 changes for a
larger number of cerebral metabolites, as T2 changes have
been postulated to reﬂect microenvironment variations
induced by pathology or naturally occurring during
development (4,5).
As spectral overlap is more severe at lower ﬁelds,
spectral editing methods are often used at 1.5 and 3 T.
Accurate quantitation of GABA and glutathione, for
example, by editing methods would beneﬁt from such a T2
assessment at these ﬁeld strengths. The methodology used
in this study can be extended to these ﬁeld strengths and
to human studies, to the extent that deconvolution
methods such as LCModel allow assessment of individual
metabolites. On the other hand, measurement of the
T2 relaxation time of coupled spin resonances is likely to
be more challenging at the ﬁeld strength of clinical
Figure 3. (A) Graphs of the simulated effect of TE on total multiplet intensities of glutamate, myo-inositol, and taurine.
Data points indicate the simulated signal intensities at each TE in the in vivo measurement. Relative maxima occur at TE
values in the range 110–130ms (TE 1/J), and ﬁrst minima at TE values60ms (TE 1/2J). (B) Semilogarithmic plot of the
normalized apparent concentration of glutamate, myo-inositol, and taurine as a function of TE derived using LCModel
analysis. An exponential ﬁt yielded T2¼89 8ms with R2¼ 0.976 for glutamate, T2¼ 14814ms with R2¼0.961 for
myo-inositol, and T2¼93 9ms with R2¼0.966 for taurine.
Table 1. Proton T2 relaxation times of cerebral metab-
olites in rat brain in vivo at 9.4 T (SDwas obtained from
the exponential ﬁtting procedure)
Metabolite T2 (ms) SD (ms) R
2
NAA 202 12 0.9843
Creatine 114 3 0.9973
Phosphocreatine 113 5 0.9921
tCr 113 3 0.9978
tCho 178 29 0.8694
Glutamate 89 8 0.9764
Taurine 93 9 0.9658
myo-Inositol 148 14 0.9608
Phosphorylethanolamine 96 12 0.9415
Glutamine 116 29 0.9019
Glucose 104 21 0.9071
GABA 105 23 0.8572
Glutathione 106 23 0.7852
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scanners because of the lower spectral resolution, as well
as the limited signal-to-noise ratio and J-modulation
effects. Given the general trend observed for singlets to
have longer T2 values at lower ﬁeld (6), the T2 values of
coupled resonances of cerebral metabolites at lower ﬁeld
are likely to be longer than those measured in the present
study.
We conclude from this study that it is feasible to
measure the T2 relaxation time of coupled spin resonances
of metabolites, provided that the signal modulation due to
J-coupling is properly taken into account by spectral
simulation.
Acknowledgements
This study was supported by Centre d’Imagerie BioMe´-
dicale (CIBM) of the UNIL, UNIGE, HUG, CHUV,
EPFL, the Leenaards and Jeantet Foundations, and SNSF
grant 3100A0-116220.
REFERENCES
1. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo
neurochemical proﬁle: quantiﬁcation of 18 metabolites in short-
echo-time 1H NMR spectra of the rat brain. J. Magn. Reson. 1999;
141: 104–120.
2. Terpstra M, Henry PG, Gruetter R. Measurement of reduced
glutathione (GSH) in human brain using LCModel analysis of
difference-edited spectra. Magn. Reson. Med. 2003; 50: 19–23.
3. Terpstra M, Ugurbil K, Gruetter R. Direct in vivo measurement
of human cerebral GABA concentration using MEGA-editing at
7 Tesla. Magn. Reson. Med. 2002; 47: 1009–1012.
4. Larvaron P, Bielicki G, Boespﬂug-Tanguy O, Renou JP. Proton
MRS of early post-natal mouse brain modiﬁcations in vivo. NMR
Biomed. 2006; 19: 180–187.
5. Lei H, Zhang Y, Zhu XH, Chen W. Changes in the proton T2
relaxation times of cerebral water and metabolites during forebrain
ischemia in rat at 9.4 T. Magn. Reson. Med. 2003; 49: 979–984.
6. de Graaf RA, Brown PB, McIntyre S, Nixon TW, Behar KL,
Rothman DL. High magnetic ﬁeld water and metabolite proton T1
and T2 relaxation in rat brain in vivo.Magn. Reson. Med. 2006; 56:
386–394.
7. Scheenen TW, Gambarota G, Weiland E, Klomp DW, Futterer JJ,
Barentsz JO, Heerschap A. Optimal timing for in vivo 1H-MR
spectroscopic imaging of the human prostate at 3T. Magn. Reson.
Med. 2005; 53: 1268–1274.
8. Mlynarik V, Gambarota G, Frenkel H, Gruetter R. Localized
short-echo-time proton MR spectroscopy with full signal-intensity
acquisition. Magn. Reson. Med. 2006; 56: 965–970.
9. Hoult DI, Richards RE. Critical factors in design of sensitive
high-resolution nuclear magnetic-resonance spectrometers. Proc.
Roy. Soc. Lond. A Math. Phys. Eng. Sci. 1975; 344: 311–340.
10. Gruetter R, Tkac I. Field mapping without reference scan using
asymmetric echo-planar techniques.Magn. Reson. Med. 2000; 43:
319–323.
11. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spec-
troscopy of rat brain at 1 ms echo time. Magn. Reson. Med. 1999;
41: 649–656.
12. Provencher SW. Estimation of metabolite concentrations from
localized in vivo proton NMR spectra. Magn. Reson. Med.
1993; 30: 672–679.
13. Mulkern R, Bowers J. Density matrix calculations of AB spectra
from multipulse sequences: quantum mechanics meets in vivo
spectroscopy. Concepts in Magnetic Resonance 1994; 6: 1–23.
14. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical
shifts and coupling constants for brain metabolites. NMR Biomed.
2000; 13: 129–153.
15. Garwood M, DelaBarre L. The return of the frequency sweep:
designing adiabatic pulses for contemporary NMR. J. Magn.
Reson. 2001; 153: 155–177.
16. Michaeli S, Garwood M, Zhu XH, DelaBarre L, Andersen P,
Adriany G, Merkle H, Ugurbil K, Chen W. Proton T2 relaxation
study of water, N-acetylaspartate, and creatine in human brain
using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn.
Reson. Med. 2002; 47: 629–633.
17. Terpstra M, Vaughan TJ, Ugurbil K, Lim KO, Schulz SC, Gruetter
R. Validation of glutathione quantitation from STEAM spectra
against edited 1H NMR spectroscopy at 4T:application to schizo-
phrenia. Magma 2005; 18: 276–282.
18. Rothman DL, Petroff OA, Behar KL, Mattson RH. Localized
1H NMR measurements of gamma-aminobutyric acid in human
brain in vivo. Proc. Natl. Acad. Sci. USA 1993; 90: 5662–5666.
Copyright # 2007 John Wiley & Sons, Ltd. NMR Biomed. 2008; 21: 396–401
DOI: 10.1002/nbm
PROTON T2 RELAXATION TIME OF J-COUPLED CEREBRAL METABOLITES 401
